Literature DB >> 25740983

Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.

Aya Shinozaki-Ushiku1, Akiko Kunita1, Maya Isogai1, Takashi Hibiya2, Tetsuo Ushiku1, Kenzo Takada3, Masashi Fukayama4.   

Abstract

UNLABELLED: Epstein-Barr virus (EBV) is one of the major oncogenic viruses and is found in nearly 10% of gastric carcinomas. EBV is known to encode its own microRNAs (miRNAs); however, their roles have not been fully investigated. The present report is the largest series to comprehensively profile the expression of 44 known EBV miRNAs in tissue samples from patients with EBV-associated gastric carcinoma. Several miRNAs were highly expressed in EBV-associated gastric carcinoma, and in silico analysis revealed that the target genes of these EBV miRNAs had functions associated with cancer-related pathways, especially the regulation of apoptosis. Apoptosis was reduced in EBV-associated gastric carcinoma tissue samples, and gastric carcinoma cell lines infected with EBV exhibited downregulation of the proapoptotic protein Bid (the BH3-interacting domain death agonist), a member of the Bcl-2 family. The luciferase activity of the reporter vector containing the 3' untranslated region of BID was inhibited by an ebv-miR-BART4-5p mimic in gastric cancer cell lines. Transfection of an ebv-miR-BART4-5p mimic reduced Bid expression in EBV-negative cell lines, leading to reduced apoptosis under serum deprivation. The inhibition of ebv-miR-BART4-5p expression was associated with partial recovery of Bid levels in EBV-positive cell lines. The results demonstrated the antiapoptotic role of EBV miRNA via regulation of Bid expression in EBV-associated gastric carcinoma. These findings provide novel insights in the roles of EBV miRNAs in gastric carcinogenesis, which would be a potential therapeutic target. IMPORTANCE: This report is the largest series to comprehensively profile the expression of 44 known EBV miRNAs in clinical samples from EBV-associated gastric carcinoma patients. Of the EBV miRNAs, ebv-miR-BART4-5p plays an important role in gastric carcinogenesis via regulation of apoptosis.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25740983      PMCID: PMC4442544          DOI: 10.1128/JVI.03639-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells.

Authors:  S Imai; J Nishikawa; K Takada
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice.

Authors:  Y Iwasaki; J M Chong; Y Hayashi; R Ikeno; K Arai; M Kitamura; M Koike; K Hirai; M Fukayama
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 3.  Epstein-Barr virus: 40 years on.

Authors:  Lawrence S Young; Alan B Rickinson
Journal:  Nat Rev Cancer       Date:  2004-10       Impact factor: 60.716

4.  Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma.

Authors:  Do Nyun Kim; Hiun-Suk Chae; Sang Taek Oh; Jin-Hyoung Kang; Cho Hyun Park; Won Sang Park; Kenzo Takada; Jae Myun Lee; Won-Keun Lee; Suk Kyeong Lee
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 5.  Epstein-Barr virus and oncogenesis: from latent genes to tumours.

Authors:  Lawrence S Young; Paul G Murray
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

6.  Epstein-Barr virus in pyothorax-associated pleural lymphoma.

Authors:  M Fukayama; T Ibuka; Y Hayashi; T Ooba; M Koike; S Mizutani
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

Review 7.  Spectrum of Epstein-Barr virus-associated diseases.

Authors:  J L Kutok; F Wang
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

8.  Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach.

Authors:  M Fukayama; Y Hayashi; Y Iwasaki; J Chong; T Ooba; T Takizawa; M Koike; S Mizutani; M Miyaki; K Hirai
Journal:  Lab Invest       Date:  1994-07       Impact factor: 5.662

9.  Epstein-Barr virus maintains lymphomas via its miRNAs.

Authors:  D T Vereide; E Seto; Y-F Chiu; M Hayes; T Tagawa; A Grundhoff; W Hammerschmidt; B Sugden
Journal:  Oncogene       Date:  2013-03-18       Impact factor: 9.867

10.  Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.

Authors:  Rumi Hino; Hiroshi Uozaki; Yoko Inoue; Yukako Shintani; Tetsuo Ushiku; Takashi Sakatani; Kenzo Takada; Masashi Fukayama
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701

View more
  43 in total

1.  Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer.

Authors:  Jia Wang; Xiang Zheng; Zailong Qin; Lingyu Wei; Yuanjun Lu; Qiu Peng; Yingxue Gao; Xuemei Zhang; Xiaoyue Zhang; Zhengshuo Li; Yuxin Fu; Peishan Liu; Can Liu; Qun Yan; Wei Xiong; Guiyuan Li; Jianhong Lu; Jian Ma
Journal:  J Biol Chem       Date:  2019-01-23       Impact factor: 5.157

2.  Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.

Authors:  Eckart Meese; Friedrich A Grässer; Hiresh Ayoubian; Nicole Ludwig; Tobias Fehlmann; Jennifer Menegatti; Laura Gröger; Eleni Anastasiadou; Pankaj Trivedi; Andreas Keller
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

3.  The identification of up-regulated ebv-miR-BHRF1-2-5p targeting MALT1 and ebv-miR-BHRF1-3 in the circulation of patients with multiple sclerosis.

Authors:  Y F Wang; D D He; H W Liang; D Yang; H Yue; X M Zhang; R Wang; B Li; H X Yang; Y Liu; Y Chen; Y X Duan; C Y Zhang; X Chen; J Fu
Journal:  Clin Exp Immunol       Date:  2017-03-28       Impact factor: 4.330

Review 4.  Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives.

Authors:  Zbigniew Wyżewski; Matylda Barbara Mielcarska; Karolina Paulina Gregorczyk-Zboroch; Anna Myszka
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

5.  A MicroRNA Derived from Adenovirus Virus-Associated RNAII Promotes Virus Infection via Posttranscriptional Gene Silencing.

Authors:  K Wakabayashi; M Machitani; M Tachibana; F Sakurai; H Mizuguchi
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

Review 6.  Epstein-Barr virus: more than 50 years old and still providing surprises.

Authors:  Lawrence S Young; Lee Fah Yap; Paul G Murray
Journal:  Nat Rev Cancer       Date:  2016-09-30       Impact factor: 60.716

Review 7.  Outlooks on Epstein-Barr virus associated gastric cancer.

Authors:  Madiha Naseem; Afsaneh Barzi; Christine Brezden-Masley; Alberto Puccini; Martin D Berger; Ryuma Tokunaga; Francesca Battaglin; Shivani Soni; Michelle McSkane; Wu Zhang; Heinz-Josef Lenz
Journal:  Cancer Treat Rev       Date:  2018-03-31       Impact factor: 12.111

8.  Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.

Authors:  Xiang Zheng; Jia Wang; Lingyu Wei; Qiu Peng; Yingxue Gao; Yuxin Fu; Yuanjun Lu; Zailong Qin; Xuemei Zhang; Jianhong Lu; Chunlin Ou; Zhengshuo Li; Xiaoyue Zhang; Peishan Liu; Wei Xiong; Guiyuan Li; Qun Yan; Jian Ma
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

9.  The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.

Authors:  Mohsen Navari; Maryam Etebari; Giulia De Falco; Maria R Ambrosio; Davide Gibellini; Lorenzo Leoncini; Pier Paolo Piccaluga
Journal:  Front Microbiol       Date:  2015-06-10       Impact factor: 5.640

10.  MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.

Authors:  Yuan Fang; Xiaoxia Zhu; Jian Wang; Na Li; Dianhe Li; Nazmus Sakib; Zhou Sha; Wen Song
Journal:  Oncotarget       Date:  2015-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.